127 related articles for article (PubMed ID: 3658049)
21. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
[TBL] [Abstract][Full Text] [Related]
22. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
[TBL] [Abstract][Full Text] [Related]
23. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
[TBL] [Abstract][Full Text] [Related]
24. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial.
Kumar S; Pandey M; Lal P; Rastogi N; Maria Das KJ; Dimri K
Radiother Oncol; 2005 May; 75(2):186-92. PubMed ID: 16086908
[TBL] [Abstract][Full Text] [Related]
25. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
26. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
Uygun K; Bilici A; Karagol H; Caloglu M; Cicin I; Aksu G; Fayda M; Uzunoglu S
Cancer Chemother Pharmacol; 2009 Aug; 64(3):601-5. PubMed ID: 19123002
[TBL] [Abstract][Full Text] [Related]
27. [Cisplatin or combined cisplatin and 60Co radiation in the treatment of advanced lung cancer--report of 145 cases].
Zhao J
Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):283-5. PubMed ID: 4085320
[TBL] [Abstract][Full Text] [Related]
28. [Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area].
Colombo A; Crispino S; Barni S; Paolorossi F; Frigerio F; Tancini G; Lissoni P; Placa F; Mazzola P; Nava S
Radiol Med; 1987 Oct; 74(4):334-7. PubMed ID: 3671803
[TBL] [Abstract][Full Text] [Related]
29. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
30. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
31. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin alone or combined with radiotherapy in advanced head and neck cancer.
Kuten A; Zidan J; Cohen Y; Robinson E
Cancer Treat Rep; 1983 Jun; 67(6):573-4. PubMed ID: 6190559
[TBL] [Abstract][Full Text] [Related]
32. Combined modality approach in the management of locally advanced head and neck cancer.
Coughlin CT; Grace M; O'Donnell JF; LeMarbre PJ; Morain WD; Geurkink NA; McIntyre OR
Cancer Treat Rep; 1984 Apr; 68(4):591-7. PubMed ID: 6201269
[TBL] [Abstract][Full Text] [Related]
33. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
34. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
35. [Intravenous mitoxantrone use and simultaneous radiotherapy as a palliative treatment in recurrent head and neck tumors].
Schnabel T; Zamboglou N; Schmitt G
Strahlenther Onkol; 1991 Oct; 167(10):599-602. PubMed ID: 1719651
[TBL] [Abstract][Full Text] [Related]
36. [Results in combined hyperthermia/radiotherapy of adenoid cystic carcinomas compared with conventional treatment].
Weischedel U; Wieland C
Strahlenther Onkol; 1987 Nov; 163(11):714-7. PubMed ID: 2825369
[TBL] [Abstract][Full Text] [Related]
37. [Initial results of hyperthermia in palliative therapy of cancers in the ENT area].
Jakse R; Steindorfer P; Germann R; Kraft-Kinz J; Hackl A; Schneider G; Scherlacher A
Laryngol Rhinol Otol (Stuttg); 1985 Feb; 64(2):52-7. PubMed ID: 2580203
[TBL] [Abstract][Full Text] [Related]
38. Radio-chemotherapy in the treatment of advanced cancer.
Machácek J; Zajíc J
Acta Univ Palacki Olomuc Fac Med; 1992; 133():61-2. PubMed ID: 1344602
[TBL] [Abstract][Full Text] [Related]
39. [Three cases of head and neck cancer made resectable by hyperthermo-chemo-radiotherapy].
Fujimura T; Yonemura Y; Kamata T; Takegawa S; Sugiyama K; Nishimura G; Miyata R; Yamaguchi A; Miyazaki I; Nakajima K
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1322-7. PubMed ID: 3430022
[No Abstract] [Full Text] [Related]
40. Integration of chemotherapy in an MFD--radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck.
Corvò R; Merlano M; Looney WB; Benasso M; Bacigalupo A; Margarino G
Head Neck; 1990; 12(1):60-5. PubMed ID: 2298565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
